Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Alzheimer Disease × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 8 Breast Neoplasms 6 Neoplasms 4 Recurrence 2 Fatigue 2 Body Weight 2 Weight Loss 1 Warts 1 Vomiting 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Insulin Resistance 1 Head and Neck Neoplasms 1 Dementia 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Asthenia 1 Anomia 1 Alzheimer Disease 1

Interventions

Standard of Care 1 Rosiglitazone 1 Hormones 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡